Versions
- 2021-05-04 (2)
- 2021-05-04 (1)
Keywords
systematic review
mechanical thrombectomy
stroke
Latin America
Categories
How to Cite
Abstract
Introduction. Stroke is a significant cause of death and disability in Latin American countries. Intravenous recombinant tissue-plasminogen activator is the standard of treatment during the first 4.5 hours since stroke onset; however, a significant proportion of patients remain untreated due to late hospital arrival. Mechanical thrombectomy (MT) revolutionised stroke care by increasing the treatment window period up to 24 hours in eligible patients. Reports from Latin American countries describing the use of MT have been published, but no systematic review approach has evaluated MT in the region. Therefore, we present a systematic review protocol to assess the availability, accessibility, effectiveness, safety, and cost-utility of MT in Latin America.
Material and methods. Randomised and non-randomised trials will be identified in CINAHL, MEDLINE, Web of Science, SciELO, EMBASE, and LILACS databases. Grey literature sources and clinical trial registries will be consulted. The approval of MT in the American Stroke Association was published in 2015; thus, the study search will be limited to papers published from 2015. The literature search will be conducted from February 1st, 2021, to March 31st, 2021. Additional search strategies will include citation tracking using Google Scholar and Web of Science and reference list check of the included articles. If necessary, authors from studies will be contacted for further data.
Results. The results will be presented following the synthesis without meta-analysis (SWIM) guidelines. Conclusions. The results of this systematic review may be helpful for clinicians, policymakers, and stakeholders in the region.
References
Ouriques Martins SC, Sacks C, Hacke W, et al. Priorities to reduce the burden of stroke in Latin American countries Lancet Neurol. 2019;18(7):674-683. doi:10.1016/S1474-4422(19)30068-7
Alrabghi L, Alnemari R, Aloteebi R, Alshammari H, Ayyad M, Al Ibrahim M, et al. Stroke types and management. Int J Community Med Public Heal. 2018;5(9):3715.
Pandian JD, Kalkonde Y, Sebastian IA, Felix C, Urimubenshi G, Bosch J. Stroke systems of care in low-income and middle-income countries: challenges and opportunities. Lancet. 2020;396(10260):1443-1451. doi:10.1016/S0140-6736(20)31374-X.
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [published correction appears in Stroke. 2019 Dec;50(12):e440-e441]. Stroke. 2019;50(12):e344-e418. doi:10.1161/STR.0000000000000211.
IHME. Data visualization [Internet]. 2020. Available from: https://vizhub.healthdata.org/gbd-compare/
Roth JM. Recombinant tissue plasminogen activator for the treatment of acute ischemic stroke. Proc (Bayl Univ Med Cent). 2011;24(3):257-259. doi:10.1080/08998280.2011.11928729.
Alonso de Leciñana M, Mazya MV, Kostulas N, et al. Stroke Care and Application of Thrombolysis in Ibero-America: Report From the SITS-SIECV Ibero-American Stroke Register. Stroke. 2019;50(9):2507–2512. doi:10.1161/STROKEAHA.119.025668.
McCarthy DJ, Diaz A, Sheinberg DL, et al. Long-Term Outcomes of Mechanical Thrombectomy for Stroke: A Meta-Analysis. ScientificWorldJournal. 2019;2019:7403104. Published 2019 May 2. doi:10.1155/2019/7403104.
Marquez-Romero JM, Góngora-Rivera F, Hernández-Curiel BC, et al. Endovascular Treatment of Ischemic Stroke in a Developing Country. Vasc Endovascular Surg. 2020;54(4):305-312. doi:10.1177/1538574420906941.
Ernesto P, Machado C, Guillermo S, Romina N, Alejandro A, Martin J, et al. TrombectomÃa mecánica en el tratamiento del accidente cerebrovascular isquémico: experiencia de un centro de alta complejidad en Argentina. 2016;8(3):145–51.
Pontes-Neto OM, Cougo-Pinto PT, Martins SC, Abud DG. A new era of endovascular treatment for acute ischemic stroke: what are the implications for stroke care in Brazil?. Arq Neuropsiquiatr. 2016;74(1):85-86. doi:10.1590/0004-282X20150191.
Nogueira RG, Lima FO, Pontes-Neto OM, et al. Randomization of endovascular treatment with stent-retriever and/or thromboaspiration versus best medical therapy in acute ischemic stroke due to large vessel occlusion trial: Rationale and design. Int J Stroke. 2021;16(1):100-109. doi:10.1177/1747493019890700.
Miñoz JG, Rivillas JA, Gonzalez N, Urrego S, Gomez JF. TrombectomÃa mecánica en pacientes con ataque cerebrovascular isquémico: serie de casos en un centro de referencia colombiano. Acta Neurológica Colomb. 2017;33(2):68–73.
Cirio JJ, Ciardi C, Vila JF, et al. Ataque cerebrovascular isquémico agudo de territorio anterior. Tratamiento endovascular [Acute ischemic stroke in anterior territory: endovascular treatment]. Medicina (B Aires). 2020;80(3):211-218.
Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020-3035. doi:10.1161/STR.0000000000000074.
Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and MetaAnalyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016 Oct 12 [cited 2020 June 06];355:i4919. Doi: https://doi.org/10.1136/bmj.i4919.
Sterne JA, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug 28 [cited 2020 June 06];366. Doi: https://doi.org/10.1136/bmj.l4898.
Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020 Jan 16 [cited 2020 June 10];368. Doi: https://doi.org/10.1136/bmj.l6890.
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. doi:10.1136/bmj.39489.470347.AD
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Ictus